Terizidone

Chemical compound
  • C
ATC code
  • J04AK03 (WHO)
Identifiers
  • 4,4'-{1,4-Phenylenebis[(E)methylylidene
    (E)azanylylidene]}bis(1,2-oxazolidin-3-one)
CAS Number
  • 25683-71-0 ☒N
PubChem CID
  • 65720
ChemSpider
  • 59144 checkY
UNII
  • 1199LEX5N8
KEGG
  • D07247 checkY
CompTox Dashboard (EPA)
  • DTXSID70905098 Edit this at Wikidata
ECHA InfoCard100.042.882 Edit this at WikidataChemical and physical dataFormulaC14H14N4O4Molar mass302.290 g·mol−13D model (JSmol)
  • Interactive image
  • O=C3NOCC3/N=C/c2ccc(/C=N/C1C(=O)NOC1)cc2
InChI
  • InChI=1S/C14H14N4O4/c19-13-11(7-21-17-13)15-5-9-1-2-10(4-3-9)6-16-12-8-22-18-14(12)20/h1-6,11-12H,7-8H2,(H,17,19)(H,18,20)/b15-5+,16-6+ checkY
  • Key:ODKYYBOHSVLGNU-IAGONARPSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Terizidone is a drug used in the treatment of tuberculosis.[1] Terizidone is mainly used in multi-drug-resistant tuberculosis (MDR-TB) in conjunction with other second-line drugs. It is a derivate of cycloserine and it is bacteriostatic.[2]

References

  1. ^ Galietti F, Giorgis GE, Oliaro A, Boaro D, Ardizzi A, Barberis S, Massaglia GM (1991). "[Tolerability to terizidone (TZ) in the treatment of pulmonary tuberculosis in dialyzed patients]". Minerva Medica. 82 (7–8): 477–81. PMID 1922892.
  2. ^ Rossiter D (2012). South African Medicines Formulary. Cape Town, South Africa: Health and Medical Publishing Group of the South African Medical Association. pp. 323–325. ISBN 978-1-875098-28-6.
  • v
  • t
  • e
Antimycobacterials, including tuberculosis treatment and leprostatic agents (J04)
Nucleic acid inhibitor
Rifamycins/
RNA polymerase inhibitor
Antifolates/DSI
ASA
Topoisomerase inhibitors/
quinolones
Protein synthesis inhibitor
Aminoglycosides
Oxazolidone
Polypeptide antibiotics
Cell envelope antibiotic
Peptidoglycan layer
Arabinogalactan layer
Mycolic acid layer
Other/unknownCombinations
Stub icon

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e